• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Intelsius launches Thermotrek products

Intelsius launches Thermotrek products

February 6, 2012
CenterWatch Staff

Intelsius, a subsidiary of DGP Life Science and a designer, manufacturer and distributor of temperature-controlled packaging solutions, has launched its new Thermotrek range of products.

The success or failure of clinical trials often depends on crucial passive climate controls to ensure the efficacy of medicines. In commercially available temperature sensitive medicines the systems ensure the patient's investment in treatment is not wasted while ensuring efficacy and safety of the medicine.

Thermotrek systems are a range of insulated, patient carrying cases designed for easy transportation of temperature sensitive medications either being tested in clinical trials or for approved and marketed medicines used by patients. The first two Thermotrek solutions are constructed with proprietary materials which provide a high level of resistance to tears or abrasions while providing stain and water resistance.

The products are qualified to maintain contents at the required temperature for up to 24 hours and designed to give many months of use.

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing